Cargando…
Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) responds poorly to systemic treatment, including new immunotherapeutic approaches. Biomarkers are urgently needed for early disease detection, patient stratification for treatment, and response prediction. The role of soluble CD40 (sCD40) is unknown in PDAC. I...
Autores principales: | Digomann, David, Heiduk, Max, Reiche, Charlotte, Glück, Jessica, Kahlert, Christoph, Mirtschink, Peter, Klimova, Anna, Bösch, Florian, Tonn, Torsten, Gaedcke, Jochen, Ghadimi, Michael, Weitz, Jürgen, Seifert, Lena, Seifert, Adrian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576756/ https://www.ncbi.nlm.nih.gov/pubmed/37838778 http://dx.doi.org/10.1038/s41698-023-00459-9 |
Ejemplares similares
-
TIGIT Expression Delineates T-cell Populations with Distinct Functional and Prognostic Impact in Pancreatic Cancer
por: Heiduk, Max, et al.
Publicado: (2023) -
Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer
por: Heiduk, Max, et al.
Publicado: (2022) -
LAG-3-Expressing Tumor-Infiltrating T Cells Are Associated with Reduced Disease-Free Survival in Pancreatic Cancer
por: Seifert, Lena, et al.
Publicado: (2021) -
VISTA Ligation Reduces Antitumor T-Cell Activity in Pancreatic Cancer
por: Digomann, David, et al.
Publicado: (2023) -
Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels
por: Seifert, Adrian M., et al.
Publicado: (2020)